Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

First patients dosed in SAVE 1 phase IIa study ATI-2173

April 22, 2021

Trevena's TRV-027 to be studied in REMAP-CAP study for COVID-19

April 21, 2021

Sinocelltech starts phase II/III development of SCTA-01 in COVID-19

April 21, 2021

Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19

April 20, 2021

Seoul National University discloses vaccine against SFTS virus

April 20, 2021

Suzhou Ark Biopharmaceutical identifies new compounds for HBV infection

April 20, 2021

Dosing begins in phase I/II study of Covigenix VAX-001 for SARS-CoV-2

April 20, 2021

Structural basis for the design of novel suramin derivatives as SARS-CoV-2 RdRp inhibitors

April 20, 2021

BerGenBio updates progress from phase II studies of bemcentinib in COVID-19

April 19, 2021

Discovery of EU-129 for treatment of severe COVID-19 in patients with underlying diseases

April 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...